# Gilles R. Dagenais

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/gilles-r-dagenais/

## Facts

| Field | Value |
| --- | --- |
| Citations | 36,093 |
| Field | Lipoproteins and Cardiovascular Health |
| h-index | 68 |
| i10-index | 137 |
| Last Known Institution | Lung Institute |
| OpenAlex ID | https://openalex.org/A5102952426 |
| ORCID iD | https://orcid.org/0000-0002-4509-2004 |
| Works | 214 |

## Researcher papers

Showing 12 of 15.

- [Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial](https://scholariq.org/papers/dulaglutide-and-cardiovascular-outcomes-in-type-2-diabetes-rewind-a-double-blind/)
- [Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease](https://scholariq.org/papers/rivaroxaban-with-or-without-aspirin-in-stable-cardiovascular-disease/)
- [Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study](https://scholariq.org/papers/modifiable-risk-factors-cardiovascular-disease-and-mortality-in-155-722/)
- [Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): a prospective cohort study](https://scholariq.org/papers/associations-of-fats-and-carbohydrate-intake-with-cardiovascular-disease-and/)
- [Small, Dense Low-Density Lipoprotein Particles as a Predictor of the Risk of Ischemic Heart Disease in Men](https://scholariq.org/papers/small-dense-low-density-lipoprotein-particles-as-a-predictor-of-the-risk-of/)
- [Cardiovascular Risk and Events in 17 Low-, Middle-, and High-Income Countries](https://scholariq.org/papers/cardiovascular-risk-and-events-in-17-low-middle-and-high-income-countries/)
- [Urinary Sodium and Potassium Excretion, Mortality, and Cardiovascular Events](https://scholariq.org/papers/urinary-sodium-and-potassium-excretion-mortality-and-cardiovascular-events/)
- [Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial](https://scholariq.org/papers/rivaroxaban-with-or-without-aspirin-in-patients-with-stable-coronary-artery/)
- [Fruit, vegetable, and legume intake, and cardiovascular disease and deaths in 18 countries (PURE): a prospective cohort study](https://scholariq.org/papers/fruit-vegetable-and-legume-intake-and-cardiovascular-disease-and-deaths-in-18/)
- [Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial](https://scholariq.org/papers/dulaglutide-and-renal-outcomes-in-type-2-diabetes-an-exploratory-analysis-of-the/)
- [Apolipoprotein A-I and B Levels and the Risk of Ischemic Heart Disease During a Five-Year Follow-up of Men in the Que´bec Cardiovascular Study](https://scholariq.org/papers/apolipoprotein-a-i-and-b-levels-and-the-risk-of-ischemic-heart-disease-during-a/)
- [Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin](https://scholariq.org/papers/safety-of-proton-pump-inhibitors-based-on-a-large-multi-year-randomized-trial-of/)

## Researcher topics

- [Lipoproteins and Cardiovascular Health](https://scholariq.org/topics/lipoproteins-and-cardiovascular-health/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)
- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)
- [Antiplatelet Therapy and Cardiovascular Diseases](https://scholariq.org/topics/antiplatelet-therapy-and-cardiovascular-diseases/)

## Researcher university

- [Lung Institute](https://scholariq.org/institutions/lung-institute/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.